ArticleInternational journal of women's health2026
A Successful Monitoring of a Pregnant Woman Suffering from Mixed Connective Tissue Disease-Associated Interstitial Lung Disease: A Case Report.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Current evidence on managing mixed connective tissue disease-associated interstitial lung disease (MCTD-ILD) during pregnancy remains scarce, and no established guidelines address this unique clinical scenario. By reporting this case, in which maternal-fetal health was optimized through multidisciplinary collaboration, dynamic monitoring, and individualized delivery planning, we aim to propose a practical and effective clinical management strategy for healthcare providers. Case Presentation: A 36-year-old primipara with an 8-year history of MCTD-ILD had long-term treatment with immunosuppressive agents such as tacrolimus, mycophenolate mofetil and hydroxychloroquine, as well as prednisone before pregnancy. Her condition was stable prior to pregnancy, and she received strict multidisciplinary team (MDT) monitoring during pregnancy. Serial assessments revealed moderate restrictive ventilatory dysfunction on pulmonary function tests and stable interstitial changes on chest CT scans, before delivery, the ILD functional categorization was comprehensively assessed as moderate based on the patient's clinical manifestations, exercise tolerance, and pulmonary function test results. Due to concerns that labor-induced stress could trigger cardiopulmonary decompensation, an elective cesarean section was performed at 39 weeks under neuraxial anesthesia, yielding a healthy male infant (Apgar score 10). Postoperative management included hydroxychloroquine, methylprednisolone initiation and continuous oxygen saturation monitoring (consistently >95%), with no maternal complications observed. The prognosis for both mother and fetus is favorable. Conclusion: Stable CTD-ILD patients can achieve successful pregnancy outcomes through preconception optimization, pregnancy-compatible immunosuppression, and MDT-guided delivery planning. Vigilant monitoring of pulmonary function, imaging, and oxygen saturation is critical, with cesarean section recommended for high-risk cases to mitigate peripartum complications. This case reinforces the need for structured risk stratification and multidisciplinary protocols to safeguard maternal and fetal well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.